Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Amlitelimab Phase 2b data show potential best-in-class profile in atopic dermatitis: Sanofi

Ruchika Sharma16 Oct 2023 1:30 PM IST

Paris: Sanofi has announced positive results from a Phase 2b study (STREAM-AD). The results showed that amlitelimab significantly improved signs...

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Granules India, NIPER ink pact to establish Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development

Ruchika Sharma16 Oct 2023 12:15 PM IST

Hyderabad: Granules India, a vertically integrated pharmaceutical company, and the esteemed National Institute of Pharmaceutical Education and...

Zydus ropes in Punit Patel as President, CEO to lead business operations in North America

Ruchika Sharma16 Oct 2023 11:10 AM IST

Ahmedabad: Zydus Lifesciences Limited, a discovery-driven, global lifesciences company has announced the appointment of Punit Patel as President and...

Andhra CM Jagan Mohan Reddy to inaugurate pharma units in Visakhapatnam today

Ruchika Sharma16 Oct 2023 10:00 AM IST

Chief Minister Jagan Mohan Reddy will inaugurate the newly constructed Adarapu building complex, Larus Labs, EUGIA Sterils Pvt Ltd company at...

EU medicines regulator recommends conditional marketing nod for Pfizer blood cancer therapy

Ruchika Sharma15 Oct 2023 2:15 PM IST

New York: The European Union medicines regulator has recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly Mirikizumab helps patients with Crohn's Disease achieve long-term Remission in Phase 3 trial

Ruchika Sharma15 Oct 2023 12:30 PM IST

Indianapolis: Eli Lilly and Company has announced that mirikizumab (an investigational interleukin-23p19 antagonist) has met the co-primary...

PBT Raises Rs 18 Crore on Social Stock Exchange for Free Healthcare Initiative

Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales

Ruchika Sharma15 Oct 2023 11:30 AM IST

New York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Late-breaking data for Fenebrutinib show brain penetration, significant reduction in lesions in patients with relapsing multiple sclerosis: Roche

Ruchika Sharma15 Oct 2023 9:00 AM IST

Basel: Roche has announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

USFDA approves Pfizer Velsipity for adults with Ulcerative Colitis

Ruchika Sharma14 Oct 2023 2:30 PM IST

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily,...

Breakthrough Made-in-India CAR-T cell therapy NexCAR19 gets DCGI nod for blood cancer treatment

Ruchika Sharma14 Oct 2023 1:30 PM IST

Dr Satyanarayana Chava, Founder-CEO of Laurus says, "We are very happy and proud to be part of this indigenously developed Cell therapy product for...

Lupin Nagpur facility completes USFDA inspection

Lupin bags tentative USFDA nod for generic equivalent of Janssen Biotech Erleada Tablets

Ruchika Sharma14 Oct 2023 1:00 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...

Zydus Lifesciences unit recalls over 7000 bottles of overactive bladder drug Oxybutynin Chloride in US

Ruchika Sharma14 Oct 2023 11:44 AM IST

The lot was produced at Ahmedabad and distributed in the US by Zydus Pharmaceuticals (USA) Inc, the US health regulator stated.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok